US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cannabis Concept

115.38

-1.9752-1.68%

Number of Gainers:9

Number of Losers:8

Number of Flat:1

PE:- -

High:118.00

Open:117.38

Low:115.38

Close:117.36

Loading ...

Teva Pharmaceuticals : UBS Cuts Target Price to $23 From $24

THOMSON REUTERS

Greenlane Holdings trading halted, news pending

Greenlane Holdings Inc. Announces Termination of Chief Growth Officer Rob Shields

Teva Releases Q2 2025 Aide Memoire

THOMSON REUTERS

Aurora Opens Medical Cannabis Access to More Canadian Consumers -- Market Talk

Tilray Brands Inc. Unveils Groundbreaking Study on THC and CBD Bioavailability in Medical Cannabis Formulations

MaxCyte Cancels AIM Market Trading for Common Stock

Could NSX be Australia’s answer to London’s AIM? Macquarie thinks so

The Australian Financial Review

Keppel Corporation Strikes Off Dormant Subsidiary KDC AIM

Electric Guitar PLC Faces Trading Suspension on AIM

Greenlane Holdings Announces 1-for-750 Reverse Stock Split Effective June 26, 2025

Tilray Stock (TSE:TLRY) Gains With Italian First

BRIEF-Veru Reports Positive Results from Phase 2b QUALITY and Maintenance Extension Study

Veru Reports Positive Results From Phase 2B Quality and Maintenance Extension Study Showing Enobosarm Significantly Reduced Body Weight Regain, Prevented Fat Regain, and Preserved Lean Mass After Semaglutide Discontinuation

THOMSON REUTERS

Veru Inc - Enobosarm Shows 93% Greater Fat Loss, 100% Lean Mass Preservation

THOMSON REUTERS

Veru Inc - Enobosarm Monotherapy Shows Positive Safety Profile With No Gi Side Effects

THOMSON REUTERS

Veru Inc - Granted FDA Meeting to Discuss Phase 3 Clinical Program

THOMSON REUTERS

Veru Inc - Enobosarm 3Mg Reduces Weight Regain by 46% After Semaglutide Discontinuation

THOMSON REUTERS

Tilray Medical Receives Italy’s First Authorization From the Ministry of Health to Distribute Medical Cannabis Flower for Therapeutic Use

THOMSON REUTERS

Tilray Brands Inc. Secures Italy’s First Authorization to Distribute Medical Cannabis Flower for Therapeutic Use

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK4557/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4557","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4557\",,,,,undefined,":{"symbol":"BK4557","market":"US","secType":"PLATE","nameCN":"Cannabis Concept","latestPrice":115.38063,"timestamp":1750967999999,"preClose":117.35582,"halted":0,"volume":243448426,"delay":0,"changeRate":-0.016831,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-1.975189,"latestTime":"06-26 16:00:00 EDT","open":117.37873,"high":117.99596,"low":115.38063,"amount":311374907.65714,"amplitude":0.022285,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1751031000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":2.195079,"peRate":-18.127035,"turnoverRate":0.05064,"increases":9,"decrements":8,"flats":0,"marketCap":36362238601,"floatMarketCap":31590391778},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4557\",,,,,undefined,":{"symbol":"BK4557","high":117.99596,"amplitude":0.022285,"preClose":117.35582,"low":115.38063,"pbRate":"2.195079","latestPrice":115.38063,"volume":243448426,"delay":0,"open":117.37873,"prevYearClose":144.8539,"prevWeekClose":116.5073,"prevMonthClose":115.0494,"prevQuarterClose":106.4635,"fiveDayClose":117.3107,"twentyDayClose":120.582,"sixtyDayClose":106.4635,"secType":"PLATE","market":"US","turnoverRate":0.05064,"peRate":-18.127035,"marketCap":36362238601,"floatMarketCap":31590391778,"timestamp":1750967999999,"nameCN":"Cannabis Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4557\",,,,undefined,":{"bkCode":"BK4557","up":9,"down":8,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4557\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2546790763","title":"Teva Pharmaceuticals : UBS Cuts Target Price to $23 From $24","url":"https://stock-news.laohu8.com/highlight/detail?id=2546790763","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546790763?lang=en_us&edition=fundamental","pubTime":"2025-06-27 16:44","pubTimestamp":1751013899,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250627:nAZN41TBDT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4557","BK4007","TEVA","BK4559","BK4566","BK4585","BK4596","BK4588","BK4584"],"gpt_icon":0},{"id":"2546075063","title":"Greenlane Holdings trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2546075063","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546075063?lang=en_us&edition=fundamental","pubTime":"2025-06-27 07:50","pubTimestamp":1750981813,"startTime":"0","endTime":"0","summary":"19:50 EDT Greenlane (GNLN) Holdings trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving break...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/greenlane-holdings-trading-halted-news-pending-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/greenlane-holdings-trading-halted-news-pending-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNLN","BK4159","BK4557"],"gpt_icon":0},{"id":"2546751194","title":"Greenlane Holdings Inc. Announces Termination of Chief Growth Officer Rob Shields","url":"https://stock-news.laohu8.com/highlight/detail?id=2546751194","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546751194?lang=en_us&edition=fundamental","pubTime":"2025-06-27 05:01","pubTimestamp":1750971666,"startTime":"0","endTime":"0","summary":"Greenlane Holdings Inc. announced a change in its management team with the termination of Rob Shields from his position as Chief Growth Officer, effective June 20, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Greenlane Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 26, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250626:nNDL7bD2LC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4557","GNLN","BK4159"],"gpt_icon":0},{"id":"2546594737","title":"Teva Releases Q2 2025 Aide Memoire","url":"https://stock-news.laohu8.com/highlight/detail?id=2546594737","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546594737?lang=en_us&edition=fundamental","pubTime":"2025-06-27 04:30","pubTimestamp":1750969800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250626:nTUA4QTHCZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TEVA","BK4559","BK4557","BK4007","BK4566","BK4588","BK4596","BK4585","BK4584"],"gpt_icon":0},{"id":"2546473768","title":"Aurora Opens Medical Cannabis Access to More Canadian Consumers -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2546473768","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546473768?lang=en_us&edition=fundamental","pubTime":"2025-06-26 23:28","pubTimestamp":1750951680,"startTime":"0","endTime":"0","summary":"1127 ET - Aurora Cannabis is opening up its compassionate pricing program in Canada to more people, which should help broaden its customer reach. Aurora expanded its program where patients earning less than C$60,000 annually are now eligible for a 30% discount on all ACB's medical cannabis, compared with a previous C$40,000 annually cutoff. TD Cowen's Derek Lessard says this improves medical cannabis affordability for out-of-pocket patients, especially in the current economic environment where consumers are more cautious. \"We believe this move also helps ACB expand its customer base and take share in the Canadian medical market,\" Lessard says. ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ACB","BK4557"],"gpt_icon":0},{"id":"2546078446","title":"Tilray Brands Inc. Unveils Groundbreaking Study on THC and CBD Bioavailability in Medical Cannabis Formulations","url":"https://stock-news.laohu8.com/highlight/detail?id=2546078446","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546078446?lang=en_us&edition=fundamental","pubTime":"2025-06-26 19:00","pubTimestamp":1750935626,"startTime":"0","endTime":"0","summary":"Tilray Brands Inc., through its division Tilray Medical, has announced the publication of a scientific study focusing on the pharmacokinetics of THC and CBD formulations. This research provides insights into the bioavailability of different cannabinoid formulations, contributing to the understanding of medical cannabis for therapeutic treatment. The study involved twelve healthy volunteers and compared the bioavailability of Tilray's THC:CBD extract with nabiximols, revealing higher THC and CBD concentrations with the Tilray extract. No serious adverse events were reported, and the results have already been presented. The findings may have implications for clinical use of these formulations.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advic","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250626:nNDLw2QW1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","LU2210150020.SGD","IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4596","BK4112","IE00B64PRP62.GBP","BK4588","BK4557","IE00B3QW5Z07.USD","BK4007","NDAQ","BK4547","TLRY","LU2210149790.SGD","BK4585"],"gpt_icon":0},{"id":"2546226492","title":"MaxCyte Cancels AIM Market Trading for Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2546226492","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546226492?lang=en_us&edition=fundamental","pubTime":"2025-06-26 05:00","pubTimestamp":1750885227,"startTime":"0","endTime":"0","summary":"MaxCyte ( ($MXCT) ) just unveiled an announcement. On June 25, 2025, MaxCyte, Inc. announced its decision to cancel the trading of its common stock...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/maxcyte-cancels-aim-market-trading-for-common-stock?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/maxcyte-cancels-aim-market-trading-for-common-stock?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","BK4539","BK4139","BK4557","AIM","MXCT"],"gpt_icon":0},{"id":"2546377224","title":"Could NSX be Australia’s answer to London’s AIM? Macquarie thinks so","url":"https://stock-news.laohu8.com/highlight/detail?id=2546377224","media":"The Australian Financial Review","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546377224?lang=en_us&edition=fundamental","pubTime":"2025-06-26 03:00","pubTimestamp":1750878000,"startTime":"0","endTime":"0","summary":"The Canadian Securities Exchange’s proposed acquisition of ASX-listed National Stock Exchange of Australia could transform the Sydney-based listings market into a significant platform for early-stage and small-cap companies, say Macquarie’s research boffins.In a note to clients, analyst Andrew Buncombe said with Canadian backing, NSX, together with Cboe, could credibly go after 544 companies, or just shy of 30 per cent of the ASX-listed market. He estimates this market is worth $50 million in revenue – $20 million in annual listings revenue, $10 million in initial public offering fees and $20 million in secondary fees.Loading...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.afr.com/street-talk/could-nsx-be-australia-s-answer-to-london-s-aim-macquarie-thinks-so-20250625-p5ma6b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"afr_stock","symbols":["BK4557","MQG.AU","BK4139","XAO.AU","AIM","XKO.AU","XJO.AU"],"gpt_icon":0},{"id":"2546214501","title":"Keppel Corporation Strikes Off Dormant Subsidiary KDC AIM","url":"https://stock-news.laohu8.com/highlight/detail?id=2546214501","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546214501?lang=en_us&edition=fundamental","pubTime":"2025-06-25 18:48","pubTimestamp":1750848515,"startTime":"0","endTime":"0","summary":"Keppel Corporation Limited ( ($SG:BN4) ) just unveiled an announcement. Keppel Corporation Limited has announced the striking-off of its indirect w...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/keppel-corporation-strikes-off-dormant-subsidiary-kdc-aim?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/keppel-corporation-strikes-off-dormant-subsidiary-kdc-aim?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4557","BK4139","BK4209","SG","AIM"],"gpt_icon":0},{"id":"2546260721","title":"Electric Guitar PLC Faces Trading Suspension on AIM","url":"https://stock-news.laohu8.com/highlight/detail?id=2546260721","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546260721?lang=en_us&edition=fundamental","pubTime":"2025-06-25 14:18","pubTimestamp":1750832281,"startTime":"0","endTime":"0","summary":"An update from Electric Guitar PLC ( ($GB:ELEG) ) is now available. Electric Guitar PLC has announced the suspension of its trading on AIM as of 25...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/electric-guitar-plc-faces-trading-suspension-on-aim?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/electric-guitar-plc-faces-trading-suspension-on-aim?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4557","AIM"],"gpt_icon":0},{"id":"2546369255","title":"Greenlane Holdings Announces 1-for-750 Reverse Stock Split Effective June 26, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2546369255","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546369255?lang=en_us&edition=fundamental","pubTime":"2025-06-25 05:00","pubTimestamp":1750798816,"startTime":"0","endTime":"0","summary":"Greenlane Holdings Inc.  has announced a one-for-seven hundred fifty reverse stock split of its Class A common stock, effective June 26, 2025. This move is intended to comply with Nasdaq's minimum bid price requirement. Trading on a post-split basis will begin on June 27, 2025, under the existing symbol \"GNLN.\" The reverse split will not change the total number of authorized shares and will affect all shareholders uniformly.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Greenlane Holdings Inc. published the original content used to generate this news brief via ACCESS Newswire  on June 24, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250624:nNDLbR8rNC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4159","BK4557","GNLN"],"gpt_icon":0},{"id":"2546773234","title":"Tilray Stock (TSE:TLRY) Gains With Italian First","url":"https://stock-news.laohu8.com/highlight/detail?id=2546773234","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546773234?lang=en_us&edition=fundamental","pubTime":"2025-06-25 00:38","pubTimestamp":1750783110,"startTime":"0","endTime":"0","summary":"It has been a while since we heard much from Canadian cannabis stock Tilray (TSE:TLRY), but it just made a little bit of history today with a new m...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/tilray-stock-tsetlry-gains-with-italian-first?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/tilray-stock-tsetlry-gains-with-italian-first?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4596","BK4547","BK4090","BK4557","BK4007","TLRY","TSE"],"gpt_icon":0},{"id":"2545287880","title":"BRIEF-Veru Reports Positive Results from Phase 2b QUALITY and Maintenance Extension Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2545287880","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545287880?lang=en_us&edition=fundamental","pubTime":"2025-06-24 20:36","pubTimestamp":1750768565,"startTime":"0","endTime":"0","summary":"BRIEF-Veru Reports Positive Results from Phase 2b QUALITY and Maintenance Extension Study June 24 (Reuters) - Veru Inc VERU.O:VERU REPORTS POSITIVE RESULTS FROM PHASE 2B QUALITY AND MAINTENANCE EXTENS","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250624:nTUABDGWZB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"BRIEF-Veru Reports Positive Results from Phase 2b QUALITY and Maintenance Extension Study","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4557","BK4584","VERU","BK4007","BK4183"],"gpt_icon":0},{"id":"2545737282","title":"Veru Reports Positive Results From Phase 2B Quality and Maintenance Extension Study Showing Enobosarm Significantly Reduced Body Weight Regain, Prevented Fat Regain, and Preserved Lean Mass After Semaglutide Discontinuation","url":"https://stock-news.laohu8.com/highlight/detail?id=2545737282","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545737282?lang=en_us&edition=fundamental","pubTime":"2025-06-24 20:30","pubTimestamp":1750768201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250624:nTUABDGWZB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4584","BK4183","BK4557","VERU","BK4007"],"gpt_icon":0},{"id":"2545282788","title":"Veru Inc - Enobosarm Shows 93% Greater Fat Loss, 100% Lean Mass Preservation","url":"https://stock-news.laohu8.com/highlight/detail?id=2545282788","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545282788?lang=en_us&edition=fundamental","pubTime":"2025-06-24 20:30","pubTimestamp":1750768201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250624:nTUABDGWZB:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4183","VERU","BK4007","BK4584","BK4557"],"gpt_icon":0},{"id":"2545282756","title":"Veru Inc - Enobosarm Monotherapy Shows Positive Safety Profile With No Gi Side Effects","url":"https://stock-news.laohu8.com/highlight/detail?id=2545282756","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545282756?lang=en_us&edition=fundamental","pubTime":"2025-06-24 20:30","pubTimestamp":1750768201,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250624:nTUABDGWZB:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4557","BK4007","VERU","BK4183","BK4584"],"gpt_icon":0},{"id":"2545282733","title":"Veru Inc - Granted FDA Meeting to Discuss Phase 3 Clinical Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2545282733","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545282733?lang=en_us&edition=fundamental","pubTime":"2025-06-24 20:30","pubTimestamp":1750768201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250624:nTUABDGWZB:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4183","BK4584","BK4557","BK4007","VERU"],"gpt_icon":0},{"id":"2545282227","title":"Veru Inc - Enobosarm 3Mg Reduces Weight Regain by 46% After Semaglutide Discontinuation","url":"https://stock-news.laohu8.com/highlight/detail?id=2545282227","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545282227?lang=en_us&edition=fundamental","pubTime":"2025-06-24 20:30","pubTimestamp":1750768201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250624:nTUABDGWZB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4557","BK4584","VERU","BK4007","BK4183"],"gpt_icon":0},{"id":"2545128962","title":"Tilray Medical Receives Italy’s First Authorization From the Ministry of Health to Distribute Medical Cannabis Flower for Therapeutic Use","url":"https://stock-news.laohu8.com/highlight/detail?id=2545128962","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545128962?lang=en_us&edition=fundamental","pubTime":"2025-06-24 19:01","pubTimestamp":1750762904,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250624:nFWN3SR0EU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","TLRY","BK4547","BK4557","BK4596"],"gpt_icon":0},{"id":"2545930289","title":"Tilray Brands Inc. Secures Italy’s First Authorization to Distribute Medical Cannabis Flower for Therapeutic Use","url":"https://stock-news.laohu8.com/highlight/detail?id=2545930289","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545930289?lang=en_us&edition=fundamental","pubTime":"2025-06-24 19:00","pubTimestamp":1750762840,"startTime":"0","endTime":"0","summary":"Tilray Brands Inc. has achieved a groundbreaking regulatory milestone in Italy, securing the first-ever authorization from the Italian Ministry of Health to distribute medical cannabis flower for therapeutic use. This approval allows Tilray Medical, a division of Tilray Brands, to introduce three new varieties of medical cannabis in Italy: Tilray THC 25%, Tilray THC 18%, and Tilray THC 9% / CBD 9%. As the first company in Italy to receive such authorization, Tilray continues to expand its leadership in the European medical cannabis market, which includes operations in Germany, Portugal, Poland, and the United Kingdom. This development represents a significant step in enhancing patient access to high-quality, EU-GMP certified cannabinoid-based therapies across Italy.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250624:nNDL8FFhhW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4547","BK4557","IE00BGHQF748.EUR","BK4588","BK4596","IE00BKPKM429.USD","LU2210150020.SGD","TLRY","NDAQ","BK4112","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","LU2210149790.SGD","LU2095319765.USD","BK4585"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":66,"code":"91000000","status":"200"}]}}